New research demonstrates that reprogramming microglia to be more aggressive against amyloid plaques could slow Alzheimer’s progression.
Category: Health & Science
Semaglutide Ozempic Linked to Fewer Bone Fractures Despite Greater Weight Loss Than Other Interventions
GLP-1 receptor agonist drugs appear to have bone-protective effects potentially through preservation of lean muscle mass during weight loss.
Most People Who Stop GLP-1 Drugs Like Ozempic Eventually Return to Medication Within a Year
New real-world data shows high rates of GLP-1 reinstatement driven by weight regain and return of metabolic health concerns after stopping.
A Daily Probiotic Supplement May Help Relieve Symptoms of Depression and Anxiety New Study Finds
Randomized trial shows probiotic supplementation leads to measurable reductions in depression and anxiety scores over a 12-week period.
Researchers Find Early Depression Clue Hidden in Children’s Eye Movement Patterns
Analysis of eye movement biomarkers in children may enable early identification of those at elevated risk for developing depressive disorders.
New Procedure Delivers Lasting Knee Arthritis Pain Relief Without Surgery Using Targeted Intervention
Minimally invasive approach to osteoarthritis pain management shows significant long-term relief in clinical study without joint replacement.
Ancient DNA Reveals Plague Was Already Killing Humans 5500 Years Ago Earlier Than Previously Thought
Genomic analysis of prehistoric human remains pushes back the earliest known dates of Yersinia pestis infection by over 1000 years.
India Supreme Court Recognizes Right to Trauma Care as Fundamental Right Under Article 21 in Landmark Ruling
SaveLIFE Foundation vs Union of India ruling imposes positive obligation on governments to create integrated trauma care systems.
India Faces Severe Trauma Burden with 67 Lakh Deaths Annually from Road Crashes Falls Burns and Disasters
India’s trauma mortality data underscores the urgency of the Supreme Court ruling mandating government action on emergency medical care.
Ozempic and Wegovy Linked to Surprising Drop in Violent Behavior in New Research Analysis
New study suggests GLP-1 receptor agonists may reduce impulsive aggression through effects on brain reward and impulse control systems.